Echocardiography and Structural Heart Symposium, 39th Annual

Miami, FL US
October 27, 2022 to October 28, 2022

Live Symposium | 13.25 Cat. 1
October 27-28, 2022 | Thursday-Friday
Hilton Miami Airport Blue Lagoon, Miami, Florida

Become an Exhibitor  

As valvular heart disease and structural heart treatments become more integral within cardiology, providers will rely on the diagnosis and treatment of disease using transcatheter/nonsurgical therapy.

The 39th Annual Echocardiography and Structural Heart Symposium – formerly known as the Echocardiography Symposium – will include successful topics from years past that focus on current guidelines for the evaluation of core topics within echocardiography, such as cardiac structure, cardiac function and hemodynamics assessment.

In addition, the internationally renowned faculty experts will address the latest developments, cutting-edge technologies and future directions of structural heart disease assessment, treatment options and advanced cardiac imaging.

These discussions will include advanced echocardiography imaging techniques (3-D, Strain, CT and TEE) and valve repair approaches (TAVR, mitral valve repair devices, left atrial appendage occlusion devices, paravalvular closure and alcohol septal ablation). Treatment focus will be on aortic, mitral and tricuspid valves and interatrial septum valvular heart disease, as well as specific patient populations, including those with cancer, atrial fibrillation, valvular heart disease and hypertrophic cardiomyopathy. Current controversies speak to indications and contraindications for various diagnostic and treatment approaches.

This year’s expanded focus will be of special interest to anesthesiologists, cardiologists, ED physicians, critical care physicians, sonographers and medical professionals interested in echocardiography and the newest advances in diagnosis and treatment of structural heart disease.

Learning Objectives

Upon completion of this symposium, participants should be better able to:

  • Utilize a multidisciplinary structural heart team approach to diagnose and treat structural heart disease.
  • Recognize the echocardiographic presentation and application of advanced imaging in patients with valvular heart disease and atrial fibrillation, including hypertrophic cardiomyopathy.
  • Demonstrate the utility of multimodality imaging in hypertrophic cardiomyopathy and workup for left atrial appendage and in valvular heart disease.
  • Assess and apply a comprehensive approach when managing the aortic, mitral and tricuspid valves and the interatrial septum, utilizing basic and advanced imaging techniques to identify and guide the treatment of valvular heart disease.
  • Utilize current evidence-based clinical data in TAVR, TMVR, MitraClip, LAA occluder devices, paravalvular leak and EtOH septal ablation to optimize treatment.
  • Demonstrate the management and utility of transesophageal and 3-D imaging in the cardiac catheterization lab to guide structural heart procedures.
  • Further define the tricuspid valve anatomy and function and describe the implications for treatment of tricuspid regurgitation using transcatheter therapy.
  • Avoid common pitfalls in imaging patients in cardio-oncology, hypertrophic cardiomyopathy and structural heart disease.
  • Define protocols that can assess valvular heart disease after intervention.

Who Should Attend

Cardiologists, vascular surgeons, interventional radiologists, anesthesiologists, emergency medicine physicians, critical care physicians, echocardiography and noninvasive vascular testing specialists, sonographers, nurses, nurse practitioners, physician assistants, pharmacists, respiratory therapists, and medical professionals interested in echocardiography and the newest advances in diagnosis and treatment of structural heart disease.

Registration and Fees

Event date: Thursday, October 27, 2022 - Friday, October 28, 2022

Attendee TypeRegistration Fee
Baptist Health Employees$110 

*International physicians and physician groups of 3 or more are eligible for a 20% discount. 
**Registration must be accompanied by a letter from the Fellowship/Residency Director.
*** Non-physician groups of 3 or more are eligible for a 10% discount

Course Summary
Available credit: 
  • 13.25 AMA PRA Category 1 Credit™
  • 13.25 General certificate of attendance
  • 13.00 Nurse Practitioners
  • 13.00 Florida Board of Nursing
  • 13.25 Florida Board of Pharmacy
  • 13.00 Florida Board of Respiratory Therapy
Course opens: 
Course expires: 
Event starts: 
10/27/2022 - 8:00am EDT
Event ends: 
10/28/2022 - 4:00pm EDT


Thursday, October 27 - 7 Cat. 1 Credits

7:00 a.m. Registration, Continental Breakfast and Visit Exhibits
7:45 a.m. Welcome and Opening Remarks
Barry Katzen, M.D.
Aortic Stenosis
Moderator: Elliott Elias, M.D.
8:00 a.m.Introduction to Valvular Heart Disease and Guideline Updates
Patrick T. O’Gara, M.D.
8:15 a.m. Sonographers' Corner: Evaluating Aortic Stenosis
Elliott Elias, M.D.
8:30 a.m. Evaluating Low-Gradient Aortic Stenosis Severity and Outcomes in TAVR vs. SAVR
Philippe Pibarot, DMV, Ph.D.
8:45 a.m.TAVR: Anatomy, Sizing, and High-Risk Features
Omar Khalique, M.D.
9:00 a.m.Imaging Post-TAVR
Philippe Pibarot, DMV, Ph.D.
9:15 a.m.Role of CMR in Aortic Stenosis
João L. Cavalcante, M.D.
9:30 a.m.Case Presentation: A Difficult Decision of TAVR vs. SAVR for My Patient
Nish Patel, M.D.
9:50 a.m.Panel Discussion with Question-and-Answer Session
Moderator: Elliott Elias, M.D.
Faculty: Patrick T. O’Gara, M.D., Philippe Pibarot, DMV, Ph.D., Omar Khalique, M.D., João L. Cavalcante, M.D., Nish Patel, M.D.
10:00 a.m.Break and Visit Exhibits
Evaluation of Prosthetic Heart Valves
Moderator: Elliott Elias, M.D.
10:15 a.m.Prosthetic Heart Valves
Patrick T. O’Gara, M.D.
10:30 a.m.Evaluation of Prosthetic Heart Valves: Form and Function
Philippe Pibarot, DMV, Ph.D.
10:45 a.m.Case Presentation: TAVR Valve-in-Valve
Ramon Quesada, M.D.
11:00 a.m.Clinical Conundrum: Is It Pathologic Obstruction or Prosthesis-Patient Mismatch?
Philippe Pibarot, DMV, Ph.D.
11:15 a.m.Panel Discussion with Question-and-Answer Session
Elliott Elias, M.D.
Faculty: Patrick T. O’Gara, M.D., Phillipe Pibarot, M.D., Ramon Quesada, M.D.
11:25 a.m.Lunch and Visit Exhibits
Learning From the Experts on Valve Disease and How They Treat and Image It
Moderator: Elliott Elias, M.D.
12:20 p.m.Should Asymptomatic Severe Valvular Heart Disease Be Treated?
Patrick T. O’Gara, M.D.
12:35 p.m.Using Advanced Imaging (Strain/Stress) to Assess MR Pre-Conception in an Athlete
Eli Friedman, M.D.
12:50 p.m.Is Stress Echo Still Necessary?
Partho P. Sengupta, M.D., D.M.
1:05 p.m.Unlocking the Mystery of When to Treat Severe Aortic Regurgitation
Maurice Enriquez-Sarano, M.D.
1:20 p.m.Role of CMR in MR and Aortic Regurgitation
João L. Cavalcante, M.D.
1:35 p.m.Panel Discussion with Question-and-Answer Session
Moderator: Elliott Elias, M.D.
Faculty: Eli Friedman, M.D., Partho P. Sengupta, M.D., D.M., Maurice Enriquez-Sarano, M.D., João L. Cavalcante, M.D.
1:45 p.m.Break and Visit Exhibits
Building on the Basics of Echo with Advanced Imaging
Moderator: Elliott Elias, M.D.
2:00 p.m. What Is an Interventional Echocardiographer or a Structural Imager?
Elliott Elias, M.D.
2:15 p.m.Prosthetic Assessment for Mitral Stenosis and Mitral Regurgitation
Philippe Pibarot, DMV, Ph.D.
2:30 p.m.How Do I Quantify Valvular Heart Disease? (PISA, Continuity, Planimetry, Regurgitant Fraction, Percentage)
Maurice Enriquez-Sarano, M.D.
2:45 p.m.Strain Without Stress: A Challenging Case in Cardio-Oncology
Socrates Kakoulides, M.D.
2:55 p.m.Strain Imaging
Partho P. Sengupta, M.D., D.M.
3:10 p.m.An Interesting Case of Constrictive vs. Restrictive Heart Disease
Socrates Kakoulides, M.D.
3:20 p.m.Panel Discussion with Question-and-Answer Session
Moderator: Elliott Elias, M.D.
Faculty: Philippe Pibarot, DMV, Ph.D., Maurice Enriquez-Sarano, M.D., Socrates Kakoulides, M.D., Partho P. Sengupta, M.D., D.M.
Multimodality Imaging for the Diagnosis and Treatment of Structural Heart Disease
Moderator: Elliott Elias, M.D.
3:30 p.m.Essential TEE Views and How They Relate to the Sonographer
Elliott Elias, M.D.
3:45 p.m.Imaging and Treatment of Cardiac Shunts (ASD/VSD/PFO)
Muhamed Saric, M.D., Ph.D.
4:00 p.m.Left Atrial Appendage
Omar Khalique, M.D.
4:15 p.m.LVH and AS: Can I Tell If This Is Amyloidosis CMP?
João L. Cavalcante, M.D.
4:30 p.m.Hypertrophic Cardiomyopathy and the Benefits of ETOH Ablations
Muhamed Saric, M.D., Ph.D.
4:45 p.m.Assessing the Right Ventricle
João L. Cavalcante, M.D.
5:00 p.m.Panel Discussion with Question-and-Answer Session
Moderator: Elliott Elias, M.D.
Faculty: Muhamed Saric, M.D., Ph.D., Omar Khalique, M.D.
5:10 p.m.Adjourn

Friday, October 28 - 6.25 Cat. 1 Credits

7:00 a.m.Registration, Continental Breakfast and Visit Exhibits
7:45 a.m.Welcome and Introductions
Elliott Elias, M.D., Damian Chaupin, M.D.
Mitral Valvular Disease Regurgitation and Right Heart Disease
Moderator: Elliott Elias, M.D.
8:00 a.m.Assessing Mitral Regurgitation
Nadira Hamid, M.D.
8:15 a.m.Imaging for MitraClip and Transcatheter Mitral Valve Replacement (TMVR)
Stephen H. Little, M.D.
8:30 a.m.Is MitraClip for Functional or Primary MR?
Maurice Enriquez-Sarano, M.D.
8:45 a.m.Aortic Regurgitation and Upcoming Transcatheter Treatment
Nadira Hamid, M.D.
9:00 a.m.An Introduction to TMVR
Omar Khalique, M.D.
9:15 a.m.CT Planning for Mitral Valve Disease
Constantino S. Pena, M.D.
9:25 a.m.My Toughest and Most Interesting Cases of TMVR
Bernardo Lopez Sanabria, M.D.
9:35 a.m.Panel Discussion with Question-and-Answer Session
Moderator: Elliott Elias, M.D.
Faculty: Nadira Hamid, M.D., Stephen H. Little, M.D., Maurice Enriquez-Sarano, M.D., Bernardo Lopez Sanabria, M.D., Omar Khalique, M.D., Constantino S. Pena, M.D.
9:50 a.m.Break and Visit Exhibits
Moderator: Damian Chaupin, M.D.
10:05 a.m.Anatomy and Echo Imaging of Tricuspid Valve
Nadira Hamid, M.D.
10:20 a.m.CT Planning for Tricuspid Valve Interventions
Omar Khalique, M.D.
10:35 a.m.How Do I Evaluate Treat and Think About Transcatheter Treatment for Tricuspid Regurgitation
Maurice Enriquez-Sarano, M.D.
10:50 a.m.My Toughest and Most Interesting Cases of Tricuspid Clip
Ramon Quesada, M.D.
11:00 a.m.TEER for TR and an Update on Transcatheter Therapy and Data for Tricuspid Regurgitation
Stephen H. Little, M.D.
11:15 a.m.Panel Discussion with Question-and-Answer Session
Moderator: Damian Chaupin, M.D.
Faculty: Nadira Hamid, M.D., Omar Khalique, M.D., Maurice Enriquez-Sarano, M.D., Ramon Quesada, M.D., Stephen H. Little, M.D.
11:30 a.m.Lunch and Visit Exhibits
Advanced Imaging
Moderator: Damian Chaupin, M.D.
12:25 p.m.An Update on Mental Health and Imaging
Orlando Santana
12:35 p.m.Evaluation of Mitral Stenosis
Elliot Elias, M.D.
12:45 p.m.An Interesting Case of Mitral Stenosis: How to Use Strain and Stress to Guide Treatment
Bernardo Lopez Sanabria, M.D.
12:55 p.m.Role of ICE in Transcatheter Therapy
Muhamed Saric, M.D., Ph.D.
1:10 p.m.Diastology: How Technology Can Assist Us
Partho P. Sengupta, M.D., D.M.
1:25 p.m.Endocarditis on the Native Valve and Prosthetic Valves and When to Send for Surgery
Muhamed Saric, M.D., Ph.D.
1:40 p.m.When and How to Use 3D/4D Imaging
Stephen H. Little, M.D.
1:55 p.m.Case Presentation: Paravalvular Leak Closure
Nish Patel, M.D.
2:10 p.m.Panel Discussion with Question-and-Answer Session
Damian Chaupin, M.D.
Faculty: Orlando Santana, Elliot Elias, M.D., Bernardo Lopez Sanabria, M.D., Partho P. Sengupta, M.D., D.M., Stephen H. Little, M.D., Nish Patel, M.D., Lowie Van Assche, M.D.
Back To Basics Rapid-Fire
Moderator: Damian Chaupin, M.D.
2:20 p.m.Will Artificial Intelligence Replace the Clinical Echocardiographer?
Damian Chaupin, M.D.
2:30 p.m.Imaging Assessment of Pulmonary Embolism
Partho P. Sengupta, M.D., D.M.
2:45 p.m.Back to Basics for Aortic Stenosis and More
Stephen H. Little, M.D.
3:00 p.m.Echocardiography and the Heart of an Athlete (Differentiating Adaptation from Pathology)
Eli Friedman, M.D.
3:15 p.m.An Interesting But Uncommon Case of MR
Elliott Elias, M.D.
3:30 p.m.Panel Discussion with Question-and-Answer Session
Moderator: Damian Chaupin, M.D.
Faculty: Elliott Elias, M.D., Partho P. Sengupta, M.D., D.M., Eli Friedman, M.D.
3:40 p.m.Closing Remarks
Elliott Elias, M.D., Damian Chaupin, M.D.
3:45 p.m.Adjourn

Return to Top  

NOTE: Schedule subject to change.

Hilton Miami Airport Blue Lagoon
5101 Blue Lagoon Dr
Miami, FL 33126
United States
+1 (305) 262-1000

The Miami Airport Hilton, just minutes from Miami International Airport, offers convenient access to beaches and attractions. Enjoy the 100-acre natural lake with jogging trail, outdoor pool and tennis and basketball courts. Indulge in spacious guest rooms and suites. This hotel was in the Top 20 of all Hotels in Miami 2015 by US News & World Report. Complimentary airport shuttle bus service is available.

Symposium Directors

imageElliott J. Elias, M.D., MPH, FACC, FASE
Medical Director of Cardiac and Structural Imaging
Miami Cardiac & Vascular Institute
Baptist Health South Florida
imageDamian F. Chaupin, M.D.
Miami Cardiac & Vascular Institute
Baptist Health South Florida


imageJoão L. Cavalcante, M.D., FASE, FACC, FSCCT, FSCMR
Director, Cardiac MRI and Structural CT Labs
Minneapolis Heart Institute at Abbott Northwestern Hospital
Director, Cardiovascular Imaging Research Center and Core Lab
Minneapolis Heart Institute Foundation
Associate Editor, European Heart Journal
Associate Editor, Journal of Cardiovascular Computed Tomography
Minneapolis, Minnesota
imageMaurice Enriquez-Sarano, M.D., FACC, FAHA, FESC
Professor, Senior Research Scientist
Minneapolis Heart Institute Foundation and the Valve Science Center
Minneapolis, Minnesota
imageEli Friedman, M.D.
Medical Director of Sports Cardiology
Baptist Health Medical Group Cardiology
Miami Cardiac & Vascular Institute
Baptist Health South Florida
Miami, Florida
imageNadira Hamid, M.D.
Assistant Professor of Medicine
Assistant Director of Structural Heart Echocardiography
Columbia University Irving Medical Center
New York, New York
imageSocrates V. Kakoulides, M.D.
Medical Director, Diagnostic Center
Miami Cardiac & Vascular Institute
Baptist Health Medical Group
Baptist Health South Florida
Miami, Florida
imageOmar Khalique, M.D.
Director, Division of Cardiovascular Imaging
Saint Francis Hospital and Catholic Health
Director, Cardiovascular Imaging Research and Education
DeMatteis Cardiovascular Institute
Roslyn, New York
imageStephen H. Little, M.D.
President, American Society of Echocardiography
Director, Cardiovascular Fellowship Program
Director of Structural Heart, Houston Methodist Hospital System
John S. Dunn Chair in Clinical Cardiovascular Research and Education
Professor of Medicine, Weill Cornell Medical College, Cornell University
Dept. of Cardiology, Houston Methodist Hospital
Houston, Texas
imageBernardo Lopez Sanabria, M.D.
Interventional Cardiologist
Miami Cardiac & Vascular Institute
Baptist Health South Florida
Miami, Florida
imagePatrick T. O’Gara, M.D.
Watkins Family Distinguished Chair in Cardiology
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
imagePhilippe Pibarot, DMV, Ph.D.
Head of Cardiology Research
Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval
Professor, Department of Medicine
Canada Research Chair in Valvular Heart Diseases
Université Laval
Quebec City, Quebec
imageRamon Quesada, M.D.
Medical Director, Structural Heart, Complex PCI & Cardiac Research
Miami Cardiac & Vascular Institute                  
Baptist Health South Florida
Miami, Florida
imageMuhamed Saric, M.D., Ph.D.
Director, Noninvasive Cardiology & Echo Lab
Professor of Medicine
New York University Langone Health
New York, New York
imagePartho P. Sengupta, M.D., D.M., FACC, FASE
Henry Rutgers Professor of Cardiology
Chief of Cardiovascular Medicine, Robert Wood Johnson Medical School
Chief of Cardiovascular Service Line, Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Disclosures And Resolution Of Conflict Of Interest

Disclosure Policy and Disclaimer


Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 13.25 credit hours by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants, CE Broker Provider #50-182. 7 credits for the Thursday session (CE Broker #20-942804) and 6.25 credits for the Friday session (CE Broker #20-942808).

American Registry for Diagnostic Medical Sonography - Sonographers and vascular technologists may use these credits to fulfill their ARDMS requirements. The ARDMS accepts AMA PRA Category 1 Credits™.

Nurses and Respiratory Therapists - Approved on a session-by-session basis for a total of 13.0 contact hours by the Florida State Board of Nursing CE Broker Provider #50-182 (7.0 credits for the Thursday session and 6.0 credits for the Friday session).

Pharmacists and Pharmacy Technicians - Approved on a session-by-session basis for a total of 13.25 contact hours by the Florida State Board of Pharmacy, CE Broker Provider #50-182; (7.0 credits for the Thursday session and 6.25 credits for the Friday session).

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.

AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.


Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.

While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.

Available Credit

  • 13.25 AMA PRA Category 1 Credit™
  • 13.25 General certificate of attendance
  • 13.00 Nurse Practitioners
  • 13.00 Florida Board of Nursing
  • 13.25 Florida Board of Pharmacy
  • 13.00 Florida Board of Respiratory Therapy

About the Exhibitors


Abbott is the global leader in developing transcatheter mitral valve technologies as alternatives to open-heart surgery. Building upon its success with the MitraClip device and many years of mitral valve experience and clinical evidence, Abbott is also leading the way in novel, transcatheter devices by investing in the development and clinical study of new mitral valve replacement technologies.  

AGFA Healthcare

Agfa HealthCare's Enterprise Imaging for Cardiology delivers a unified imaging ecosystem that speeds up image acquisition and retrieval and enhances the delivery of care.
It improves the cardiologist’s experience, by offering across all cardiology departments and modalities - Ultrasound, Cath lab, ECG, Nuclear Cardiology and MR&CT- web-based image viewing and access, advanced analysis applications, structured reporting, flexible workflow and collaboration tools – in ONE SINGLE WORKSPACE.
Agfa HealthCare Enterprise Imaging for Cardiology is part of our unified Enterprise Imaging Platform, built to reduce complexity, improve productivity and deliver value. 


AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. 


We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realize the potential of what science can do.

Biosense Webster

Increase insight into the heart during transseptal punctures. The ACUSON AcuNav™ Catheter provides high resolution 2D grayscale and Doppler models that help better understand structural orientation, visualize cardiac chamber borders and verify tissue contact. The ACUSON AcuNav™ Catheter is intended for intracardiac and intraluminal visualization of cardiac & great vessel anatomy and physiology as well as visualization of other devices in the heart

Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare.

B. Braun Interventional Systems

B. Braun Interventional Systems offers state of the art medical devices designed and developed to provide innovative solutions that add value, safety, efficiency, and precision to interventional procedures. Our products have been developed in collaboration with, and in response to, the specific needs of physicians, technologists and nurses with the intent to improve patient outcomes. Our product portfolios consist of angioplasty and valvuloplasty, congenital and structural heart, percutaneous drainage, vena cava filters, vascular access and interventional accessories, and have been developed to specifically address clinical needs in interventional radiology, pediatric and congenital interventional cardiology, vascular surgery and pulmonology. 

Bracco Diagnostics

Bracco Diagnostics is a diagnostic imaging company with products for X-ray imaging, including computed tomography, magnetic resonance imaging, ultrasound and nuclear medicine


CardiaLine is a medical device distribution company that specializes in comprehensive cardiopulmonary solutions. CardiaLine offers diagnostic and non-diagnostic cardiopulmonary monitoring systems, remote patient monitoring solutions and durable medical exercise equipment, with a specialty in cardiac and pulmonary rehab. CardiaLine has created partnerships with global companies such as Ergoline GmbH as we work to bring quality solutions to patient care.


Chiesi USA, Inc., headquartered in Cary, NC, is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. For more information, please visit or call our customer service department at (888) 466-6505

CIVCO Medical Solutions

CIVCO Medical Solutions works to make image-guided procedures safer. CIVCO manufactures products for use in diagnostic and therapeutic imaging and interventional procedures, with a strong focus on ultrasound. CIVCO specializes in ASTRA automated high-level disinfection systems for TEE transducers, ultrasound viral barriers, and needle and device guidance.

East End Medical

The SafeCrossTM Transseptal RF Puncture and Steerable Balloon Introducer System is used for introducing various cardiovascular catheters into the heart, including the left side of the heart. The system enables left heart access through a puncture of the atrial septum during a transseptal catheterization procedure. In addition, the device can be used for monitoring intracardiac pressures, sampling blood, and infusing solutions.

Edwards Lifesciences

Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.


Eko, a digital health company, is advancing how healthcare professionals detect and monitor heart and lung disease with its innovative suite of digital tools, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible.

Fujifilm Healthcare

Fujifilm Healthcare pioneered ultrasound for use by cardiovascular professionals since the 1960’s and we continue to lead the way with the introduction of our premium 2D and 3D ultrasound system, the LISENDO 880. Recognized for our outstanding image quality, Doppler performance, superior system reliability and intuitive use of cutting edge technology like Vector Flow Mapping(VFM), Fujifilm Healthcare remains the ideal choice for exceptional diagnostic ultrasound in Cardiovascular medicine. Our focus on hemodynamic analysis in echocardiography uniquely positions us to provide additional information not typically found in Fetal, Pediatric and Adult echocardiography. Fujifilm Healthcare is redefining the vision for cardiovascular ultrasound.

GE Cardiovascular Ultrasound

GE Healthcare is the $18 billion healthcare business of GE. As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 47,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Ginkgo Heart

The Cormeum app was designed to make managing heart failure easy. Patients can check in anytime to see their day by day, weekly or monthly progress. Best of all, they can share their results with you so that together you can collaborate on their care. Empower, educate and engage your patients by recommending Cormeum and providing them an opportunity to self-manage their heart failure.

Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals is a global biopharmaceutical company that finds and delivers novel treatments for patients with significant unmet need. In March 2021, Kiniksa received FDA approval for ARCALYST® (rilonacept).  Please visit to learn more.

Lantheus Medical Systems

With more than 60 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit

LSI Medical

In today’s every-changing healthcare environment, LSI leads the way in providing time-saving cardiac rehab solutions you trust, supported by relationships you rely on. Together, we keep your focus on where it’s needed most – on your patients. 


We engineer the extraordinary to alleviate pain, restore health, and extend life.

Miami Cardiac & Vascular Institute

Miami Cardiac & Vascular Institute is the largest and most comprehensive cardiovascular facility in the region. The team of multilingual, multidisciplinary specialists pioneered the development of minimally invasive techniques used to treat aneurysms, blockages in veins and arteries and holes in the heart. The Institute leverages the power of Baptist Health’s combined resources of experts, pioneering research, compassionate caregivers and leading-edge treatments and technology.

MiCare Path

Building a closer connection with an ever-growing patient population, MiCare Path is a reimbursable integrated mobile health (mHealth)* platform delivering improved outcomes with data driven decisions, personalized patient education and care paths promoting clinical efficiencies for a better patient experience.


Novarad has been providing medical imaging software solutions for over 30 years. We are experts in hospital deployment of CPACS and medical enterprise imaging and information software systems. Our software includes scalable and customizable solutions for 500+ bed hospitals down to 26 bed hospitals, Critical Access Hospitals, and Rural Hospitals. The NovaCardio solution is a complete motion cardiac imaging solution that allows viewing, efficient workflows, and cardiac structured reporting. In addition it allows physicians to use story boarding to graphically share the complete picture of a patient’s disease. Novarad has best-in-class, USA based, 24/7 Support.


Novo Nordisk purpose is to drive change to defeat diabetes and other serious chronic diseases such as CVD, obesity, rare blood and rare endocrine diseases. Novo Nordisk is the first pharmaceutical company to use 100% renewable power in all of their global production facilities. With their Circular for Zero strategy, they are starting a journey to achieve zero environmental impact in all of their business activities. Most important we strive in innovation to improve patient lives.

Pfizer Rare Disease

We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.

Philips Ultrasound

Today’s cardiology departments are under pressure to implement cutting-edge imaging solutions that will not compromise workflow efficiency, diagnosis, treatment or patient care. At Philips, we understand your challenges as well as your commitment to providing outstanding diagnosis and care, fast. We also believe that, through specialized, patient-centric care, we can improve both outcomes and experiences.

Rhythmedix Cardiac Monitoring

RhythMedix is a leading integrated provider of continuous, cloud based remote arrhythmia monitoring solutions serving physicians and their patients throughout the United States. Focused on innovation within the monitoring space, the latest 1-piece patch device continues to disrupt the marketplace by providing a 4-in-1 monitor without the burdensome need for a phone to complicate and delay sending data. Thus, allowing a quick and seamless patient experience.


Sanofi is an innovative, patient centric global healthcare company. We are committed to using state of the art technology to solve some of the world’s greatest health risks including cardiovascular disease and diabetes to improve our patient’s quality of life and longevity.  

Siemens Healthineers

By constantly bringing breakthrough innovations to market, Siemens Healthineers enables healthcare professionals to deliver high-quality care, leading to the best possible outcome for patients. At Siemens Healthineers, our mission is to enable healthcare providers to increase their value by equipping them with our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services. Our global portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways. With our strengths in patient twinning, precision therapy, as well as digital, data, and artificial intelligence (AI), we are well positioned to take on the biggest challenges in healthcare. We will continue to build on these strengths to help fight the world’s most threatening diseases, improving the quality of outcomes, and enabling access to care.


Ultromics’ AI-powered platform, EchoGo, is revolutionizing echocardiography. Proven to predict patient outcomes, this groundbreaking solution automates complex analysis through a secure cloud connection. With unprecedented accuracy and zero variability, Ultromics empowers providers with superior heart disease detection and risk stratification.

ZOLL Medical

ZOLL Medical Corporation develops products to protect and manage cardiac patients, including the LifeVest wearable cardioverter defibrillator (WCD), ZOLL Cardiac Monitor, and ZOLL Heart Failure Management System.


Please login or register to take this course.

COVID-19 Protocols Notice for All Attendees, Exhibitors and Vendors

Self-screening is required for all in-person attendees. If you have any symptoms of respiratory illness, you must refrain from attending in person.

CDC Self-Screening Tool

Please be sure to read our COVID Protocols for all in-person education prior to registering for this activity.

Learn More